Mean scale and test scores obtained by patients with glioma and controls
| All glioma patients | Group I | Group II | Group III | Group IV | Healthy subjects | Chronic disease patients | |
|---|---|---|---|---|---|---|---|
| ADL, Activity Daily Living; AM, Attentive Matrices; FLIC, Functional Living Index—Cancer; KPS, Karnofsky Performance Status; RCPM, Raven’s Coloured Progressive Matrices; SR, Story Recall; SRDS, Self Rating Depression Scale; STAI1/2, State Trait Anxiety Inventory 1/2; TMTA/B, Trail Making Test A/B. | |||||||
| STAI1 | 42.90 (10.91) | 45.18 (11.67) | 43.13 (10.93) | 39.22 (8.98) | 41.69 (10.96) | 26.95 (8.05) | 47.08 (12.09) |
| STAI2 | 42.58 (10.71) | 42.45 (10.85) | 43.83 (12.35) | 41.33 (8.67) | 41.76 (9.65) | 29.85 (9.25) | 42.70 (10.66) |
| SRDS | 39.08 (9.25) | 40.63 (9.43) | 39.56 (10.49) | 36.83 (7.86) | 37.15 (7.35) | 28.41 (8.23) | 37.41 (7.65) |
| FLIC | 105.77 (23.40) | 103.75 (22.83) | 103.90 (26.02) | 108.44 (22.38) | 111.53 (21.04) | – | 105.45 (19.49) |
| ADL | 16.73 (2.49) | 16.90 (2.51) | 16.60 (2.66) | 16.44 (2.59) | 17.00 (2.12) | – | 17.20 (1.56) |
| KPS | 79.26 (15.67) | 80.90 (14.65) | 75.66 (14.78) | 80.55 (18.30) | 81.53 (16.75) | – | – |
| RCPM | 26.02 (6.71) | 25.39 (6.10) | 26.26 (6.77) | 27.16 (7.59) | 25.46 (7.34) | 32.64 (3.34) | 26.00 (5.21) |
| AM | 41.50 (13.22) | 42.06 (13.52) | 39.53 (12.78) | 40.50 (14.03) | 46.00 (12.62) | 57.66 (2.44) | 50.79 (6.20) |
| TMTA | 120.64 (104.40) | 120.21 (108.48) | 130.13 (106.20) | 119.66 (102.44) | 101.23 (101.65) | 35.77 (12.45) | 75.75 (39.83) |
| TMTB | 290.02 (209.64) | 252.33 (154.53) | 310.83 (227.47) | 339.77 (243.20) | 268.76 (242.68) | 93.75 (30.16) | 185.00 (113.17) |
| SR | 8.69 (5.22) | 8.78 (5.61) | 8.28 (5.14) | 8.83 (4.98) | 9.19 (5.28) | 16.10 (4.37) | 10.64 (4.74) |